BioSpace News Archive

BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company.

HOYA Corporation and a subsidiary through PENTAX Medical division, Pentax of America, Inc. (collectively, “PENTAX” or “the Company”), today finalized a Deferred Prosecution Agreement (DPA) with the U.S. Department of Justice (DOJ) on issues related to the timely filing of Medical Device Reports (MDRs) for PENTAX Medical’s duodenoscopes

Mullen Technologies has begun the manufacturing process for portable ventilators out of the Company’s high voltage battery R&D center in Monrovia, CA, in an effort to aid in the critical shortages hospitals around the world are currently facing.

CDC-approved technique will allow caregivers to use disposable masks up to three times

The speculations regarding using the corona virus as a weapon of bioterrorism can be used about diseases such as smallpox as well. Persistence market research report highlights the fact that though the smallpox is eradicated from the world, there are chances of an outbreak of this virus by mischievous intent of people closely associated with vaccinia virus stored in laboratories.

The COVID-19 outbreak has created turbulence across the supply chain, taking a toll on the healthcare industry.

Growing awareness amongst the public and government is creating scope for vaccination of other diseases such as Hepatitis B. According to the PMR report, public awareness will play a vital role in the surge of hepatitis B vaccinations.

Modifications to the outline of Study P02 requested to ensure a harmonized global study protocol complying with requirements from EMA as well as FDA

Acquisition Creates One-Stop-Shop for Medication Advisory, CE Learning Solutions, Sterile Compounding Best Practices, and Consulting and Educational Strategies for Pharmacists, Pharmacy Technicians, Prescribers, Nurses, and Clinicians

The Robert Wood Johnson Foundation will provide $50 million in immediate short-term relief to several national and community organizations to help some of the families and communities feeling the greatest strain under the COVID-19 health emergency.